On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy

On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Samia Mora
Robert J Glynn
S Matthijs Boekholdt
Nordestgaard, Børge
John J P Kastelein
Paul M Ridker

The goal of this study was to determine whether residual risk after high-dose statin therapy for primary prevention individuals with reduced levels of low-density lipoprotein cholesterol (LDL-C) is related to on-treatment apolipoprotein B, non-high-density lipoprotein cholesterol (non-HDL-C), trigylcerides, or lipid ratios, and how they compare with on-treatment LDL-C.

Originalsprog	Engelsk
Tidsskrift	Journal of the American College of Cardiology
Vol/bind	59
Udgave nummer	17
Sider (fra-til)	1521-8
Antal sider	8
ISSN	0735-1097
DOI	https://doi.org/10.1016/j.jacc.2011.12.035
Status	Udgivet - 2012

ID: 48541628

Institut for Klinisk Medicin

On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)